Signe Erickson is currently Chief Scientific Officer at Spiral Therapeutics, a start-up company focused on delivering therapeutics for hearing loss. Prior to joining Spiral, she played key roles in the conception and development of several ophthalmic drug delivery technologies, including polymeric formulation approaches and devices, while in research positions at the Johns Hopkins University, the University of Southern California and SurModics. Most recently she provided technical and clinical leadership for the Port Delivery System development while in roles at ForSight Vision4 and Genentech. Dr. Erickson earned a mechanical engineering degree (B.S.) from Auburn University and a bioengineering degree (Ph.D.) from the Georgia Institute of Technology. She is an inventor on over 20 issued U.S. patents related to drug delivery, drug formulation, and medical devices.